International AIDS Society-USA
   Welcome   COW Editorial Board   CME Accreditation   Grant Support   Mailing List   Presentations   Return to Main Site 
 
 

Disclosures

The members of the Cases on the Web (COW) Editorial Board are volunteers and are not compensated for their role in overseeing the online COW activities.

Below are the financial interests with commercial companies of each member of the COW Editorial Board within the last 12 months of the date of disclosure (noted next to each):

Dr Saag provided grant and/or research support for Achillion Pharmaceutical, Boehringer-Ingelheim, Gildead Sciences, GlaxoSmithKline, Merck and Co, Inc,Panacos, Pfizer/Agouron, Progenics, Roche Laboratories, Serono, Tibotec, Trimeris, and Vertex. He served as a consultant for Achillion Pharmaceutical, Avexa, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck and Co, Inc, Monogram Biosciences, Panacos, Pfizer/Agouron, Progenics, Roche Laboratories, Tanox, Tibotec/Virco, Trimeris, and Vertex. He is a member of the Speakers Bureau of all of the aforementioned commercial companies. (Updated 8/24/2006)

Dr Lampiris provided grants and research support to Gilead Sciences, GlaxoSmithKline, Abbott Laboratories, and Roche Pharmaceuticals. He also served as a paid lecturer for Boehringer-Ingelheim. (Updated 1/17/2007)

Dr Bedimo served as scientific advisor to Abbott Laboratories and Gilead Sciences. He provided grants and research support to Abbott Laboratories, Bristol-Myers Squibb, Tibotec Therapeutics, and Merck and Co, Inc. (Updated 1/31/07)

Dr Sax served as a consultant for Abbott Laboratories, Bristol-Myers Squibb, Gilead, and GlaxoSmithKline. He also provided grants and research support for Bristol Myers-Squibb, Pfizer Global Pharmaceuticals, and Merck and Co, Inc. (Updated 12/11/06)

Dr Glesby served as a consultant and provided grants and research support for for Serono Laboratories. He was a paid lecturer for Abbot Laboratories. (Updated 12/14/06)

Coming Soon

Dr Aberg

Dr Newman

Dr Johnson

 

 

 
Back to Top